• Joaquín Zúñiga, Martha Torres, Javier Romo, Diana Torres, Luis Jiménez, Gustavo Ramírez, Alfredo Cruz, Enrique Espinosa, Teresa Herrera, Ivette Buendía, Alejandra Ramírez-Venegas, Yolanda González, Karen Bobadilla, Fernando Hernández, Jorge García, Francisco Quiñones-Falconi, Eduardo Sada, María E Manjarrez, Carlos Cabello, Simón Kawa, Albert Zlotnik, Annie Pardo, and Moisés Selman.
• Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Mexico DF, Mexico. joazu@yahoo.com
• Autoimmunity. 2011 Nov 1;44(7):562-70.

AbstractThe immune mechanisms underlying the pathogenesis of severe pneumonia associated with the A/H1N1 virus are not well known. The objective of this study was to determine whether severe A/H1N1-associated pneumonia can be explained by the emergence of particular T-cell subsets and the cytokines/chemokines they produced, as well as distinct responses to infection. T-cell subset distribution and cytokine/chemokine levels in peripheral blood and bronchoalveolar lavage (BAL) were determined in patients with severe A/H1N1 infection, asymptomatic household contacts, and healthy controls. Cytokine and chemokine production was also evaluated after in vitro infection with seasonal H1N1 and pandemic A/H1N1 strains. We found an increase in the frequency of peripheral Th2 and Tc2 cells in A/H1N1 patients. A trend toward increased Tc1 cells was observed in household contacts. Elevated serum levels of IL-6, CXCL8, and CCL2 were found in patients and a similar cytokine/chemokine profile was observed in BAL, in which CCL5 was also increased. Infection assays revealed that both strains induce the production of several cytokines/chemokines at 24 and 72 h, however, IL-6, CCL3, and CXCL8 were strongly up-regulated in 72-h cultures in presence of the A/H1N1 virus. Several inflammatory mediators are up-regulated in peripheral and lung samples from A/H1N1-infected patients who developed severe pneumonia. In addition, the A/H1N1 strain induces higher levels of pro-inflammatory cytokines and chemokines than the seasonal H1N1 strain. These findings suggest that it is possible to identify biomarkers of severe pneumonia and also suggest the therapeutic use of immunomodulatory drugs in patients with severe pneumonia associated with A/H1N1 infection.

44 keywords...

hide…